Bernard Davidow
New York City Department of Health and Mental Hygiene
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Bernard Davidow.
American Journal of Drug and Alcohol Abuse | 1981
Balkrishena Kaul; Bernard Davidow
Urine specimens from methadone treatment clinics were screened for various abused drugs between 1974-1979 by thin-layer chromatography (TLC) and immunoassay techniques (IAT). A comparison of the relative incidence of drugs abused reveals that IAT are more sensitive and detect far greater number of subjects abusing drugs than TLC. The results also show a significant abuse of heroin and cocaine during the period studied and a variation of the incidence of other drugs used during the same period. While these patients did not receive benzodiazepenes and tricyclic antidepressants by prescription, their abuse alone and in combination with each other was also found to be widespread. Low levels of PCP and/or its analogs were found in 1978 and 1979. The frequent finding of low levels of PCP in combination with other drugs indicates the availability of this hallucinogen and point to its use in combination with other illicit drugs such as cocaine, amphetamine, and heroin. The suggestion is made that more sensitive analytical methods for drugs screening be utilized in methadone monitoring programs, and that other classes of drugs be added than are currently required.
Archives of Environmental Health | 1983
Balkrishena Kaul; Bernard Davidow; Yee M. Eng; Marvin H. Gewirtz
A pilot study was initiated to examine cord blood from approximately 300 newborns of various ethnic groups from two New York City hospitals for lead (Pb), erythrocyte protoporphyrin (EP), ferritin (FRT), and hemoglobin (Hb) levels during 1979 and 1980. Results showed an overall mean Pb level of 8 +/- 4 micrograms/dl, EP level of 61 +/- 26 micrograms/dl [geometric mean (GM) = 66.36], FRT level of 165 +/- 107 ng/ml (GM = 135.99), and a distribution frequency of Hb with nearly 69% between 13.5 and 16.9 g % (mean +/- standard deviation = 15 +/- 1), 20% below 13.4 g % (12 +/- 2 g %), and 11% at or above 17.0 g % (18 +/- 1 g %). Both EP and FRT showed a bimodal distribution. There was a negative correlation between blood EP and plasma FRT levels that was significant at the .03% level. The study also showed that a significant drop in mean cord blood Pb levels occurred compared with earlier studies. Follow up of newborns with mildly elevated Pb and EP levels should be made and screening of mothers for Pb levels during early pregnancy should constitute a part of prenatal care, particularly for those from urban areas with previously demonstrated environmental Pb hazard.
Clinical Chemistry | 1973
Bernard Searle; Wing Cheong Chan; Bernard Davidow
American Journal of Clinical Pathology | 1966
Bernard Davidow; Nicolo Li Petri; Babington Quame; Bernard Searle; Eugene Fastlich; Joseph Savitzky
Archive | 1978
Balkrishena Kaul; Bernard Davidow; Stephen J. Millian
Journal of Analytical Toxicology | 1991
Karl Verebey; Yee M. Eng; Bernard Davidow; Alex Ramon
Clinical Chemistry | 1967
Bernard Searle; Milutin B. Mijuskovic; Daniel Widelock; Bernard Davidow
Clinical Toxicology | 1980
Balkrishena Kaul; Bernard Davidow
Journal of Analytical Toxicology | 1977
Balkrishena Kaul; Babington Quame; Bernard Davidow
Journal of Analytical Toxicology | 1977
Balkrishena Kaul; Bernard Davidow; Stephen J. Millian